Friday, Jan 31, 2025 · SEC filings

What the smart money revealed on Jan 31

Real insider buys24insiders · $1.53M
Real insider sales51insiders · $86.7M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

556 insider filings came in. We hid 39 planned (10b5-1) sellers and 427 people whose filings were routine, like grants and tax withholding.

trending_up

Calamos Strategic Total Return Fund (CSQ) VP and CFO Thomas Herman bought $425K

23,190 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 29–30
$425K
trending_up

Comstock Resources (CRK) Director Elizabeth Davis bought $200K

10,725 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Sep 9
$200K
trending_up

Oak Valley Bancorp (OVLY) Director H. Randolph Holder Jr. bought $156K

6,000 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 4 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 4 of 4 beat Traded Jan 29
$156K
trending_up

MSC Income Fund (MSIF) Managing Director Nicholas Meserve bought $155K

10,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 30
$155K
trending_down

Abbott Laboratories (ABT) Executive Vice President Hubert Allen sold $24.3M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 184,806 shares directly.

Real sale Form 4 Traded Jan 29–30
$24.3M
trending_down

Tempus AI (TEM) CEO and Chairman Eric Lefkofsky sold $13.3M

Not marked as a planned 10b5-1 sale. Sold 4% of the shares they held directly. Still holds 5.53M shares.

Real sale Form 4 Traded Jan 29–31
$13.3M
trending_down

Ryan Specialty (RYAN) Director Nicholas Cortezi sold $2.63M

Not marked as a planned 10b5-1 sale. Sold every share held directly.

Real sale Form 4 Sold 100% of stake Traded Jan 29–30
$2.63M
Show 20 more real buys
NWBI Northwest Bancshares · Director Timothy Hunter · Traded Jan 31
$131K
BHRB Burke & Herbert Financial Services · Director Gary Hinkle · Traded Jan 31
$64.5K
RGLS Regulus Therapeutics · CEO Joseph Hagan · Traded Jan 30
$54.5K
NWFL Norwood Financial · Director Ronald Schmalzle · Traded Jan 30
$52K
TLSI TriSalus Life Sciences · CEO and President Mary Szela · Traded Jan 29–30
$51.8K
TBTC Table Trac · Director Andrew Berger · Traded Jan 30
$47.3K
COSM Cosmos Health · CEO Grigorios Siokas · Traded Jan 30
$33.9K
FRD Friedman Industries · Director Sandra Scott · Traded Jan 27–29
$24.2K
RGLS Regulus Therapeutics · Director David Baltimore · Traded Jan 30
$20.8K
TRST Trustco Bank Corp N Y · Executive Vice President and COO Kevin Curley · Traded Jan 29
$20.1K
PIIVX Private Shares Fund · Director Herbert Morgan · Traded Jan 30
$20K
WULF TeraWulf · Director Michael Bucella · Traded Jan 27
$20K
ETST Earth Science Tech · Director Yovan Sanchez · Traded Jan 31
$18K
OTLC Oncotelic Therapeutics · Chairman and CEO Vuong Trieu · Traded Jan 29–31
$10.4K
PCSA Processa Pharmaceuticals · Director Justin Yorke · Traded Jan 27
$9.92K
NRIM Northrim Bancorp · Director Shauna Hegna · Traded Jan 31
$9.49K
AUBN Auburn National Bancorporation · Director David Housel · Traded Jan 30
$4.38K
RCG RENN Fund · President and CEO Murray Stahl · Traded Jan 30
$3.57K
KWY Kingsway Financial Services · President and CEO John Fitzgerald · Traded Jan 30
$2.5K
KWY Kingsway Financial Services · CFO and EVP Kent Hansen · Traded Jan 30
$308
Show 48 more real sales
PCAR Paccar · Executive Vice President Darrin Siver · Traded Jan 31
$11.6M
BLK BlackRock · Senior Managing Director J. Richard Kushel · Traded Jan 30
$10.7M
ABT Abbott Laboratories · Executive Vice President Daniel Salvadori · Traded Jan 30
$3.05M
TDY Teledyne Technologies · Executive Chairman Robert Mehrabian · Traded Jan 31
$2.99M
NTRS Northern Trust · COO Peter Cherecwich · Traded Jan 29
$2.94M
PCAR Paccar · CEO R. Preston Feight · Traded Jan 31
$2.8M
DHR Danaher · Senior Vice President - GC Brian Ellis · Traded Jan 30
$1.28M
BPOP Popular · Executive Vice President Eli Sepulveda · Traded Jan 30
$1.05M
BPOP Popular · Executive Vice President Eduardo Negron · Traded Jan 30
$1.04M
LNN Lindsay · President and CEO Randy Wood · Traded Jan 30
$1.04M
VLY Valley National Bancorp · Sevp Joseph Chillura · Traded Jan 29–30
$1.03M
PGR Progressive · CRM President Lori Niederst · Traded Jan 30
$952K
SANM Sanmina · Director Eugene Delaney · Traded Jan 30
$835K
PGC Peapack Gladstone Financial · Sevp Gregory Smith · Traded Jan 30
$563K
PLXS Plexus · Exec VP Angelo Ninivaggi Jr. · Traded Jan 30
$497K
VZ Verizon Communications · EVP and Group CEO-VZ Business Kyle Malady · Traded Jan 29
$453K
CPZ Calamos Long/Short Equity & Dynamic Income Trust · VP and CFO Thomas Herman · Traded Jan 29–30
$418K
SMBC Southern Missouri Bancorp · Director Douglas Bagby · Traded Jan 30
$414K
ALK Alaska Air Group · SVP Legal and GEN Counsel Kyle Levine · Traded Jan 29
$314K
ILLR Triller Group · Director Robert Diamond Jr. · Traded Jan 29–31
$305K
PLMR Palomar · CEO and Chairman Mac Armstrong · Traded Jan 29
$265K
NTRS Northern Trust · President/Wealth Management Jason Tyler · Traded Jan 30
$252K
PCAR Paccar · Vice President Todd Hubbard · Traded Jan 31
$224K
SLB Schlumberger Limited · Chief People Officer Bejar Rando · Traded Jan 31
$223K
FFIV F5 · Director Marianne Budnik · Traded Jan 30
$222K
RBCAA Republic Bancorp · EVP John Rippy · Traded Jan 30
$203K
ALK Alaska Air Group · SVP People Andrea Schneider · Traded Jan 30
$134K
EWBC East West Bancorp · Director Jack Liu · Traded Jan 30
$133K
WGS GeneDx · CEO Katherine Stueland · Traded Jan 29
$130K
PLMR Palomar · CFO T. Christopher Uchida · Traded Jan 29
$54.9K
PLMR Palomar · President Jon Christianson · Traded Jan 29
$51.8K
WABC Westamerica Bancorporation · SVP/Banking Division Manager Robert Baker Jr. · Traded Jul 22–Jan 29
$50K
HOPE Hope Bancorp · Sevp Thomas Stenger · Traded Jan 30
$49.5K
PLMR Palomar · Chief Legal Officer Angela Grant · Traded Jan 29
$42.7K
PLMR Palomar · Chief Risk Officer Jonathan Knutzen · Traded Jan 29
$41.1K
BOH Bank of Hawaii · Vice Chair Taryn Salmon · Traded Jan 30
$33.7K
OSIS OSI Systems · Pres. Paul Morben · Traded Jan 30
$30.9K
WGS GeneDx · CFO Kevin Feeley · Traded Jan 29
$21.6K
ABEO Abeona Therapeutics · Director Mark Alvino · Traded Jan 29
$21.5K
CDR-PB Cedar Realty Trust · CEO Michael Franklin · Traded Jan 29
$13.4K
CMRX Chimerix · VP of Finance and Accounting David Jakeman · Traded Jan 30
$11.5K
CMRX Chimerix · President and CEO Michael Andriole · Traded Jan 30
$9.63K
ENBP ENB Financial · Chief Risk Officer Nicholas Klein · Traded Jan 31
$8.77K
CMRX Chimerix · CFO Michelle LaSpaluto · Traded Jan 30
$4.17K
CBUS Cibus · Director Gerhard Prante · Traded Jan 30
$2.83K
BENF Beneficient · Officer Jeff Welday · Traded Jan 29–31
$1.04K
DBVT DBV Technologies S.A. · Chief Medical Officer Pharis Mohideen · Traded Jan 30
$510
VJET Catheter Precision · Director Martin Colombatto · Traded Jan 29
$1

13F season

Holdings as of Dec 31, 2024 are due Feb 14

81 funds have filed so far. 58 filed for the quarter before.

Biggest real insider buys, Jan 25–31

Open-market buys by officers and directors, filed in the 7 days up to Jan 31.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist